Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-093060
Filing Date
2024-08-07
Accepted
2024-08-07 18:00:04
Documents
2
Period of Report
2024-07-30

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1607
2 EX-24 etnb-ex24.htm EX-24 9726
  Complete submission text file 0000950170-24-093060.txt   12818
Mailing Address C/O FIVE PRIME THERAPEUTICS, INC. 2 CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address
Sarena Francis Willard (Reporting) CIK: 0001423786 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39122 | Film No.: 241185284

Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Issuer) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)